Sarepta Therapeutics, Inc. (SRPT)

NASDAQ: SRPT · Real-Time Price · USD

23.03

+1.24 (5.69%)

At close: May 6, 2026, 4:00 PM EDT

21.84

-1.19 (-5.17%)

After-hours: May 6, 2026, 7:55 PM EDT

Sarepta Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	464.45	801.28	1,103	428.43	966.78	2,116
Short-Term Investments	188.74	138.37	251.78	1,248	1,023	-
Cash & Short-Term Investments	653.19	939.65	1,355	1,676	1,989	2,116
Cash Growth	24.95%	-30.64%	-19.18%	-15.74%	-5.98%	9.15%
Accounts Receivable	394.82	398.23	601.99	400.33	214.63	152.99
Inventory	1,001	914.74	749.96	322.86	203.97	186.21
Other Current Assets	260.76	285.31	366.72	179.9	149.89	149.03
Total Current Assets	2,310	2,538	3,073	2,579	2,558	2,604
Net Property, Plant & Equipment	460.3	470.62	488.65	357.11	244.99	236.69
Other Intangible Assets	-	-	-	-	-	14.24
Long-Term Investments	81.94	1.05	133.16	-	-	-
Other Long-Term Assets	326.82	340.1	267.9	328.14	325.51	292.95
Total Assets	3,179	3,350	3,963	3,265	3,128	3,148
Accounts Payable	70.38	280.84	214.44	164.92	95.88	76.74
Accrued Expenses	302.37	359.66	373.51	315	419	271.7
Current Portion of Long-Term Debt	-	-	-	105.48	-	-
Current Portion of Leases	-	-	-	-	15.49	-
Unearned Revenue	116.04	443.4	130.26	50.42	89.24	89.24
Other Current Liabilities	10.38	11.39	13.47	17.85	-	15.05
Total Current Liabilities	499.16	1,095	731.68	653.66	619.6	452.73
Long-Term Debt	838.16	828.97	1,137	1,133	1,544	1,097
Long-Term Leases	198.51	199.38	192.47	140.97	57.58	41.51
Other Long-Term Liabilities	138	85.44	374.15	478.1	521.94	628.84
Total Long-Term Liabilities	1,175	1,114	1,704	1,752	2,124	1,767
Total Liabilities	1,674	2,209	2,435	2,405	2,743	2,220
Common Stock	0.01	0.01	0.01	0	0.01	0.01
Treasury Stock	-25.26	-25.26	-	-	-	-
Additional Paid-in Capital	6,077	6,043	5,739	5,305	4,297	4,135
Accumulated Other Comprehensive Income	-0.12	0.27	-0.22	0.92	-1.66	-0.02
Retained Earnings	-4,546	-4,877	-4,211	-4,446	-3,910	-3,207
Shareholders' Equity	1,505	1,141	1,528	859.34	384.95	928.01
Total Liabilities & Equity	3,179	3,350	3,963	3,265	3,128	3,148
Total Debt	1,037	1,028	1,330	1,379	1,617	1,138
Net Cash (Debt)	-383.48	-88.7	25.2	297.29	372.02	977.48
Net Cash Growth	-	-	-91.53%	-20.09%	-61.94%	12.91%
Net Cash Per Share	-3.54	-0.89	0.23	3.22	4.25	12.03
Book Value	1,505	1,141	1,528	859.34	384.95	928.01
Book Value Per Share	13.89	11.39	14.16	9.30	4.40	11.42
Tangible Book Value	1,505	1,141	1,528	859.34	384.95	913.77
Tangible Book Value Per Share	13.89	11.39	14.16	9.30	4.40	11.24

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q